Browse by Research Project Code

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Doszpoly, A., de la Cuesta, F., Lopez-Gordo, E., Bénézech, C., Nicklin, S. A. and Baker, A. H. (2019) Human adenovirus serotype 5 is sensitive to IgM-independent neutralization in vitro and in vivo. Viruses, 11(7), 616. (doi: 10.3390/v11070616) (PMID:31284434) (PMCID:PMC6669743)

Low, E. L., Baker, A. H. and Bradshaw, A. C. (2019) TGFβ, smooth muscle cells and coronary artery disease: a review. Cellular Signalling, 53, pp. 90-101. (doi: 10.1016/j.cellsig.2018.09.004) (PMID:30227237) (PMCID:PMC6293316)

MacAskill, M. G. et al. (2018) Robust revascularization in models of limb ischemia using a clinically translatable human stem cell-derived endothelial cell product. Molecular Therapy, 26(7), pp. 1669-1684. (doi: 10.1016/j.ymthe.2018.03.017) (PMID:29703701) (PMCID:PMC6035339)

Duffy, M.R., Doszpoly, A., Turner, G., Nicklin, S.A. and Baker, A.H. (2016) The relevance of coagulation factor X protection of adenoviruses in human sera. Gene Therapy, 23(7), pp. 592-596. (doi: 10.1038/gt.2016.32) (PMID:27014840) (PMCID:PMC4940928)

Stevens, H. C., Deng, L., Grant, J. S., Pinel, K., Thomas, M., Morrell, N. W., MacLean, M. R. and Baker, A. (2016) Regulation and function of miR-214 in pulmonary arterial hypertension. Pulmonary Circulation, 6(1), pp. 109-117. (doi: 10.1086/685079) (PMID:27162619) (PMCID:PMC4860547)

Alonso-Padilla, J., Papp, T., Kaján, G. L., Benkő, M., Havenga, M., Lemckert, A., Harrach, B. and Baker, A. H. (2016) Development of novel adenoviral vectors to overcome challenges observed with HAdV-5 based constructs. Molecular Therapy, (doi: 10.1038/mt.2015.194) (PMID:26478249) (PMCID:PMC4754553)

Deng, L. et al. (2015) MicroRNA-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension. Circulation Research, 117(10), pp. 870-883. (doi: 10.1161/CIRCRESAHA.115.306806) (PMID:26311719) (PMCID:PMC4620852)

McDonald, R. A. et al. (2015) Reducing in-stent restenosis therapeutic manipulation of miRNA in vascular remodeling and inflammation. Journal of the American College of Cardiology, 65(21), pp. 2314-2327. (doi: 10.1016/j.jacc.2015.03.549) (PMID:26022821) (PMCID:PMC4444526)

Duffy, M., Ma, J., Deng, L., Dakin, R. S., Uil, T., Custers, J., Kelly, S. M. , McVey, J. H., Nicklin, S. A. and Baker, A. H. (2015) Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo. PLoS Pathogens, 11(2), e1004673. (doi: 10.1371/journal.ppat.1004673) (PMID:25658827) (PMCID:PMC4450073)

McDonald, R. A. et al. (2013) miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation. European Heart Journal, 34(22), pp. 1636-1643. (doi: 10.1093/eurheartj/eht105)

Baker, A. H. and Delles, C. (2013) Is microRNA-376c a biomarker or mediator of preeclampsia? Hypertension, 61(4), pp. 767-769. (doi: 10.1161/HYPERTENSIONAHA.111.00087)

Howard, L., MacKenzie, R. M., Pchelintsev, N. A., McBryan, T., McClure, J. D. , McBride, M. W. , Kane, N. M., Adams, P. D., Milligan, G. and Baker, A. H. (2013) Profiling of transcriptional and epigenetic changes during directed endothelial differentiation of human embryonic stem cells identifies FOXA2 as a marker of early mesoderm commitment. Stem Cell Research and Therapy, 4(2), Art. 36. (doi: 10.1186/scrt192)

This list was generated on Sun Apr 2 10:17:47 2023 BST.